SlideShare a Scribd company logo
D-:GROUP
Prof. Masood-ul-Hassan Javed
Saadi Aljundi ID: 11110044
Abdulrahman Hameed ID:11110042
Ali Abdulghafor ID:11110061
Yaser Alhodaithy ID:11110071
Mustafa Fouad ID:11110120
Hamad Emad Dhuhayr ID:10110067
Scientific
Assignment
5.1Block
Contents
Introduction
Material and method
result
Discuses
4
1
2
3
5 Conclusion
6 References
7
( a pharmacological company which study the development of
antibiotics).
 facilitated by laboratories and materials for performing
pharmacological and microbial antibiotics’ researches
 having a specialized section for the animal experiments.
 the company has a research on new antibiotics.
To study the effectiveness of an antibiotic by:
– Firstly, pharmacological experiment. (vitro)
– Secondly, Microbiological experiment. (vitro)
– Thirdly, experiment on animal (vivo)
– And finally these experiments will enable us to test the drug on
humans
INTRODUCTIONANDAIMS
1) Antibiotic SAAHYM.
2) Animal models:- Rabbits.
3) criteria:- used 12 male healthy rabbits.
4) Housing:- They were put in a big, quiet cage and
germfree room with good ventilation, and were exposed to
the sun light at temperature of 27C°.
5) feeding:- They were fed thrice a day, at the early
morning, the afternoon, and the evening each followed by
collection of urine samples.
Material and method
Pharmacological part:-
In this part, we test if the drug is metabolized in the liver
and if it stable in the stomach or not.
 to examine metabolism by a liver homogenate.
 to test stability by used solution of ph= 2.
 to divide 6 rabbits to 2 groups.
Microbiological part:-
In this part, we study the bacteria in aerobic culture and
the effect of the antibiotic SAAHYM on them.
 Sterilization of loop in order to put the sample s to form
inoculation and distribute it by “blood agar media”.
 additionally test were performed such as urease and coagulase
test.
 measured the sensitivity the drug by “disk diffusion method”
 Selected 6 male rabbits divided into two groups of three
Con>>Material and method
 Pharmacological Part:-
-From this table we can observe that the drug is metabolized by the
liver and at the same time is stable (not hydrolyzed) in the stomach.
- After HPLC analysis of the rabbits’ urine, the experimental group
showed presence of the drug metabolites in the urine.
Result
 Microbiological part:-
Finally after doing the experiments we found out that:
• SAAHYM is effective because of the widest clear zone around
the bacteria
• And hence, we can complete the test and apply the drug on Vivo.
Result con>>
Pharmacological Part:-
 before take any new drugs we have to experiment it in
animal.
 when test it we have to concern on its metabolism
and affect the highly acidic on it by stomach.
 we used liver homogenate to test the metabolism.
 we used the animals’ urine because, after
metabolism, the drugs are converted to hydrophilic
substances so they can be excreted via urine.
Discuses
Microbiological part:-
 (NW 2101) is a new discovered type of bacteria that causes
(RBCs hemolysis mediated exotoxin) which is resistant to all
known antibiotics. It’s mechanism of resistance is based on
the presence of the enzymes β-lactamases.
 The antibiotic SAAHYM’s mechanism of action is through
stoppage of the bacterial cell wall synthesis and stimulating
the autolytic enzymes present in the cell wall of the bacteria.
Discuses con>>
 After the successful results followed this experiment, we
need further research and studies to detect any side effects
that may result from this new drug, and also to see the
possibility of using and applying this drug in a clinical trial in
the future.
 After the successful results followed this experiment, we
need further research and studies to detect any side effects
that may result from this new drug, and also to see the
possibility of using and applying this drug in a clinical trial in
the future.
Conclusion
 H. P. Rang, M.M. Dale, J.M. Ritter, R.J. Flower, G. Henderson:
Rang and Dale’s Pharmacology. 7th Edition. (Elsevier Inc. 2012).
Chapters: 49-50
 C.K.Bnniker, R.Ananthanarayan. Textbook of microbiology, 8th
edition (Universities Press (India 2009-2010)). Chapters: 4,
5,6,66.
 Richard A. Harvey, Pamela C. Champe: Lippincott’s Illustrated
Reviews Microbiology. 2nd Edition. ( Lippincott’s Williams &
Wiklins 2007). Chapter:19
 Lectures, papers, journals about Animal Experiment provided by
Maastricht University and Alrajhi Colleges.
References
Thank you

More Related Content

What's hot

Chronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlookChronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlook
RxVichuZ
 
Toxicokinetics toxicology pre-clinical pharmacology
Toxicokinetics  toxicology  pre-clinical pharmacologyToxicokinetics  toxicology  pre-clinical pharmacology
Toxicokinetics toxicology pre-clinical pharmacology
Dilip Kawane
 
Bioequivalence in adv.
Bioequivalence in adv.Bioequivalence in adv.
Bioequivalence in adv.
Surang Judistprasert
 
1.protocol for toxicity study
1.protocol for toxicity study1.protocol for toxicity study
1.protocol for toxicity study
Saranya Sasi
 
Bio assy of antibiotics & vit d
Bio assy of antibiotics & vit dBio assy of antibiotics & vit d
Bio assy of antibiotics & vit d
buner12345
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
Himanshu Yadav
 
Ba&be new'
Ba&be new'Ba&be new'
Inhalation Toxicity Studies- OECD guidelines
 Inhalation Toxicity Studies- OECD guidelines Inhalation Toxicity Studies- OECD guidelines
Inhalation Toxicity Studies- OECD guidelines
Cerin Philip
 
Nanoparticle technology for_drug_delivery
Nanoparticle technology for_drug_deliveryNanoparticle technology for_drug_delivery
Nanoparticle technology for_drug_delivery
Sainal Edi Kamal
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
KhushbooThakur15
 
bioequivalence study design
bioequivalence study designbioequivalence study design
bioequivalence study design
Juhi Priya
 
Toxicokinetics of pharmdians
Toxicokinetics of pharmdians Toxicokinetics of pharmdians
Toxicokinetics of pharmdians
Sugunapharmd
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
Dr Ajay Mandal
 
Inprocess quality control tests for biological products
Inprocess quality control tests for biological productsInprocess quality control tests for biological products
Inprocess quality control tests for biological products
nishathfathima
 
Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404
Dr Ajay Mandal
 
BIOAVAILABILITY AND BIOEQUIVALENCE
BIOAVAILABILITY AND BIOEQUIVALENCEBIOAVAILABILITY AND BIOEQUIVALENCE
BIOAVAILABILITY AND BIOEQUIVALENCE
AVIJIT BAKSHI
 
Testing of Dermatotoxicity by OECD guidelines
Testing of Dermatotoxicity by OECD guidelinesTesting of Dermatotoxicity by OECD guidelines
Testing of Dermatotoxicity by OECD guidelines
GAUTAM KHUNE
 
Basis for bcs based biowaiver
Basis for bcs based biowaiverBasis for bcs based biowaiver
Basis for bcs based biowaiver
Mohammed Abdeen
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).
Dr Ajay Mandal
 
Bioavailability and bioequivalance studies
Bioavailability and bioequivalance studies Bioavailability and bioequivalance studies
Bioavailability and bioequivalance studies
ROHIT
 

What's hot (20)

Chronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlookChronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlook
 
Toxicokinetics toxicology pre-clinical pharmacology
Toxicokinetics  toxicology  pre-clinical pharmacologyToxicokinetics  toxicology  pre-clinical pharmacology
Toxicokinetics toxicology pre-clinical pharmacology
 
Bioequivalence in adv.
Bioequivalence in adv.Bioequivalence in adv.
Bioequivalence in adv.
 
1.protocol for toxicity study
1.protocol for toxicity study1.protocol for toxicity study
1.protocol for toxicity study
 
Bio assy of antibiotics & vit d
Bio assy of antibiotics & vit dBio assy of antibiotics & vit d
Bio assy of antibiotics & vit d
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
 
Ba&be new'
Ba&be new'Ba&be new'
Ba&be new'
 
Inhalation Toxicity Studies- OECD guidelines
 Inhalation Toxicity Studies- OECD guidelines Inhalation Toxicity Studies- OECD guidelines
Inhalation Toxicity Studies- OECD guidelines
 
Nanoparticle technology for_drug_delivery
Nanoparticle technology for_drug_deliveryNanoparticle technology for_drug_delivery
Nanoparticle technology for_drug_delivery
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
 
bioequivalence study design
bioequivalence study designbioequivalence study design
bioequivalence study design
 
Toxicokinetics of pharmdians
Toxicokinetics of pharmdians Toxicokinetics of pharmdians
Toxicokinetics of pharmdians
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
 
Inprocess quality control tests for biological products
Inprocess quality control tests for biological productsInprocess quality control tests for biological products
Inprocess quality control tests for biological products
 
Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404
 
BIOAVAILABILITY AND BIOEQUIVALENCE
BIOAVAILABILITY AND BIOEQUIVALENCEBIOAVAILABILITY AND BIOEQUIVALENCE
BIOAVAILABILITY AND BIOEQUIVALENCE
 
Testing of Dermatotoxicity by OECD guidelines
Testing of Dermatotoxicity by OECD guidelinesTesting of Dermatotoxicity by OECD guidelines
Testing of Dermatotoxicity by OECD guidelines
 
Basis for bcs based biowaiver
Basis for bcs based biowaiverBasis for bcs based biowaiver
Basis for bcs based biowaiver
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).
 
Bioavailability and bioequivalance studies
Bioavailability and bioequivalance studies Bioavailability and bioequivalance studies
Bioavailability and bioequivalance studies
 

Similar to test antibiotic on vivo

Preclinical studies, clinical trails and pharmacovigilance
Preclinical studies, clinical trails and pharmacovigilancePreclinical studies, clinical trails and pharmacovigilance
Preclinical studies, clinical trails and pharmacovigilance
kamrudeen samani
 
Pre clinical studies
Pre clinical studiesPre clinical studies
Pre clinical studies
Kirsha K S
 
Drug development
Drug developmentDrug development
Drug development
DrReuben Syiem
 
Preclinacal
PreclinacalPreclinacal
Preclinacal
VishalGalave2
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
PurushothamKN1
 
New drug development process
New drug development processNew drug development process
New drug development process
SameerKhasbage
 
New Drug Discovery And Development (part-2)
New Drug Discovery And Development (part-2)New Drug Discovery And Development (part-2)
New Drug Discovery And Development (part-2)
swatisejwani
 
Drug discovery & development
Drug discovery & developmentDrug discovery & development
Drug discovery & development
Shubham Patil
 
A review on stages of drug development and alternative methods for animal stu...
A review on stages of drug development and alternative methods for animal stu...A review on stages of drug development and alternative methods for animal stu...
A review on stages of drug development and alternative methods for animal stu...
Frinto Francis
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
Azeemsales
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
Azeemsales
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.
Audumbar Mali
 
In silico lead discovery technique.pptx
In silico lead discovery technique.pptxIn silico lead discovery technique.pptx
In silico lead discovery technique.pptx
SIRAJUDDIN MOLLA
 
Assignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening MethodAssignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening Method
Deepak Kumar
 
Introduction to practical pharmacology
Introduction to practical pharmacologyIntroduction to practical pharmacology
Introduction to practical pharmacology
Likith `HV
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
aiswarya thomas
 
Phase 1 protocol
Phase 1 protocolPhase 1 protocol
Phase 1 protocol
Dr Renju Ravi
 
BIOEQUIVALENCE STUDIES.pptx
BIOEQUIVALENCE STUDIES.pptxBIOEQUIVALENCE STUDIES.pptx
BIOEQUIVALENCE STUDIES.pptx
Shiva Kant Thakur
 
From the test tube to the market
From the test tube to the marketFrom the test tube to the market
From the test tube to the market
anitajoshi
 
Pre Clinical Studies
Pre Clinical StudiesPre Clinical Studies
Pre Clinical Studies
Debashish Sarkar
 

Similar to test antibiotic on vivo (20)

Preclinical studies, clinical trails and pharmacovigilance
Preclinical studies, clinical trails and pharmacovigilancePreclinical studies, clinical trails and pharmacovigilance
Preclinical studies, clinical trails and pharmacovigilance
 
Pre clinical studies
Pre clinical studiesPre clinical studies
Pre clinical studies
 
Drug development
Drug developmentDrug development
Drug development
 
Preclinacal
PreclinacalPreclinacal
Preclinacal
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
 
New drug development process
New drug development processNew drug development process
New drug development process
 
New Drug Discovery And Development (part-2)
New Drug Discovery And Development (part-2)New Drug Discovery And Development (part-2)
New Drug Discovery And Development (part-2)
 
Drug discovery & development
Drug discovery & developmentDrug discovery & development
Drug discovery & development
 
A review on stages of drug development and alternative methods for animal stu...
A review on stages of drug development and alternative methods for animal stu...A review on stages of drug development and alternative methods for animal stu...
A review on stages of drug development and alternative methods for animal stu...
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.
 
In silico lead discovery technique.pptx
In silico lead discovery technique.pptxIn silico lead discovery technique.pptx
In silico lead discovery technique.pptx
 
Assignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening MethodAssignment on Alternatives to Animal Screening Method
Assignment on Alternatives to Animal Screening Method
 
Introduction to practical pharmacology
Introduction to practical pharmacologyIntroduction to practical pharmacology
Introduction to practical pharmacology
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
 
Phase 1 protocol
Phase 1 protocolPhase 1 protocol
Phase 1 protocol
 
BIOEQUIVALENCE STUDIES.pptx
BIOEQUIVALENCE STUDIES.pptxBIOEQUIVALENCE STUDIES.pptx
BIOEQUIVALENCE STUDIES.pptx
 
From the test tube to the market
From the test tube to the marketFrom the test tube to the market
From the test tube to the market
 
Pre Clinical Studies
Pre Clinical StudiesPre Clinical Studies
Pre Clinical Studies
 

More from HAMAD DHUHAYR

Kawasaki disease
Kawasaki disease Kawasaki disease
Kawasaki disease
HAMAD DHUHAYR
 
Approch to cough in children
Approch to cough in childrenApproch to cough in children
Approch to cough in children
HAMAD DHUHAYR
 
Typical antipsychotic
Typical antipsychoticTypical antipsychotic
Typical antipsychotic
HAMAD DHUHAYR
 
Personality disorder - cluster C
Personality disorder - cluster CPersonality disorder - cluster C
Personality disorder - cluster C
HAMAD DHUHAYR
 
Amniotic fluid disorder
Amniotic fluid disorderAmniotic fluid disorder
Amniotic fluid disorder
HAMAD DHUHAYR
 
liver abscess
liver abscess liver abscess
liver abscess
HAMAD DHUHAYR
 
nerve injury
nerve injurynerve injury
nerve injury
HAMAD DHUHAYR
 
Hirdschsprug disease
Hirdschsprug disease Hirdschsprug disease
Hirdschsprug disease
HAMAD DHUHAYR
 
Postoperative fever -hamad
Postoperative fever -hamadPostoperative fever -hamad
Postoperative fever -hamad
HAMAD DHUHAYR
 
Ulner nerve
Ulner nerveUlner nerve
Ulner nerve
HAMAD DHUHAYR
 
Retention of urine
Retention of urine Retention of urine
Retention of urine
HAMAD DHUHAYR
 
Parathyroid
Parathyroid Parathyroid
Parathyroid
HAMAD DHUHAYR
 
Esophagial carcinoma
Esophagial carcinoma Esophagial carcinoma
Esophagial carcinoma
HAMAD DHUHAYR
 
Atropine
Atropine Atropine
Atropine
HAMAD DHUHAYR
 
Lower back pain
Lower back painLower back pain
Lower back pain
HAMAD DHUHAYR
 
SCC
SCCSCC
Upper git bleeding
Upper git bleeding Upper git bleeding
Upper git bleeding
HAMAD DHUHAYR
 
Hsv,ebs,cmv and hzv
Hsv,ebs,cmv and hzvHsv,ebs,cmv and hzv
Hsv,ebs,cmv and hzv
HAMAD DHUHAYR
 
ABG
ABGABG
Thyrotoxicosis in pregnancy - hamad
Thyrotoxicosis in pregnancy - hamadThyrotoxicosis in pregnancy - hamad
Thyrotoxicosis in pregnancy - hamad
HAMAD DHUHAYR
 

More from HAMAD DHUHAYR (20)

Kawasaki disease
Kawasaki disease Kawasaki disease
Kawasaki disease
 
Approch to cough in children
Approch to cough in childrenApproch to cough in children
Approch to cough in children
 
Typical antipsychotic
Typical antipsychoticTypical antipsychotic
Typical antipsychotic
 
Personality disorder - cluster C
Personality disorder - cluster CPersonality disorder - cluster C
Personality disorder - cluster C
 
Amniotic fluid disorder
Amniotic fluid disorderAmniotic fluid disorder
Amniotic fluid disorder
 
liver abscess
liver abscess liver abscess
liver abscess
 
nerve injury
nerve injurynerve injury
nerve injury
 
Hirdschsprug disease
Hirdschsprug disease Hirdschsprug disease
Hirdschsprug disease
 
Postoperative fever -hamad
Postoperative fever -hamadPostoperative fever -hamad
Postoperative fever -hamad
 
Ulner nerve
Ulner nerveUlner nerve
Ulner nerve
 
Retention of urine
Retention of urine Retention of urine
Retention of urine
 
Parathyroid
Parathyroid Parathyroid
Parathyroid
 
Esophagial carcinoma
Esophagial carcinoma Esophagial carcinoma
Esophagial carcinoma
 
Atropine
Atropine Atropine
Atropine
 
Lower back pain
Lower back painLower back pain
Lower back pain
 
SCC
SCCSCC
SCC
 
Upper git bleeding
Upper git bleeding Upper git bleeding
Upper git bleeding
 
Hsv,ebs,cmv and hzv
Hsv,ebs,cmv and hzvHsv,ebs,cmv and hzv
Hsv,ebs,cmv and hzv
 
ABG
ABGABG
ABG
 
Thyrotoxicosis in pregnancy - hamad
Thyrotoxicosis in pregnancy - hamadThyrotoxicosis in pregnancy - hamad
Thyrotoxicosis in pregnancy - hamad
 

Recently uploaded

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 

Recently uploaded (20)

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 

test antibiotic on vivo

  • 1. D-:GROUP Prof. Masood-ul-Hassan Javed Saadi Aljundi ID: 11110044 Abdulrahman Hameed ID:11110042 Ali Abdulghafor ID:11110061 Yaser Alhodaithy ID:11110071 Mustafa Fouad ID:11110120 Hamad Emad Dhuhayr ID:10110067 Scientific Assignment 5.1Block
  • 3. ( a pharmacological company which study the development of antibiotics).  facilitated by laboratories and materials for performing pharmacological and microbial antibiotics’ researches  having a specialized section for the animal experiments.  the company has a research on new antibiotics. To study the effectiveness of an antibiotic by: – Firstly, pharmacological experiment. (vitro) – Secondly, Microbiological experiment. (vitro) – Thirdly, experiment on animal (vivo) – And finally these experiments will enable us to test the drug on humans INTRODUCTIONANDAIMS
  • 4. 1) Antibiotic SAAHYM. 2) Animal models:- Rabbits. 3) criteria:- used 12 male healthy rabbits. 4) Housing:- They were put in a big, quiet cage and germfree room with good ventilation, and were exposed to the sun light at temperature of 27C°. 5) feeding:- They were fed thrice a day, at the early morning, the afternoon, and the evening each followed by collection of urine samples. Material and method
  • 5. Pharmacological part:- In this part, we test if the drug is metabolized in the liver and if it stable in the stomach or not.  to examine metabolism by a liver homogenate.  to test stability by used solution of ph= 2.  to divide 6 rabbits to 2 groups. Microbiological part:- In this part, we study the bacteria in aerobic culture and the effect of the antibiotic SAAHYM on them.  Sterilization of loop in order to put the sample s to form inoculation and distribute it by “blood agar media”.  additionally test were performed such as urease and coagulase test.  measured the sensitivity the drug by “disk diffusion method”  Selected 6 male rabbits divided into two groups of three Con>>Material and method
  • 6.  Pharmacological Part:- -From this table we can observe that the drug is metabolized by the liver and at the same time is stable (not hydrolyzed) in the stomach. - After HPLC analysis of the rabbits’ urine, the experimental group showed presence of the drug metabolites in the urine. Result
  • 7.  Microbiological part:- Finally after doing the experiments we found out that: • SAAHYM is effective because of the widest clear zone around the bacteria • And hence, we can complete the test and apply the drug on Vivo. Result con>>
  • 8. Pharmacological Part:-  before take any new drugs we have to experiment it in animal.  when test it we have to concern on its metabolism and affect the highly acidic on it by stomach.  we used liver homogenate to test the metabolism.  we used the animals’ urine because, after metabolism, the drugs are converted to hydrophilic substances so they can be excreted via urine. Discuses
  • 9. Microbiological part:-  (NW 2101) is a new discovered type of bacteria that causes (RBCs hemolysis mediated exotoxin) which is resistant to all known antibiotics. It’s mechanism of resistance is based on the presence of the enzymes β-lactamases.  The antibiotic SAAHYM’s mechanism of action is through stoppage of the bacterial cell wall synthesis and stimulating the autolytic enzymes present in the cell wall of the bacteria. Discuses con>>
  • 10.  After the successful results followed this experiment, we need further research and studies to detect any side effects that may result from this new drug, and also to see the possibility of using and applying this drug in a clinical trial in the future.  After the successful results followed this experiment, we need further research and studies to detect any side effects that may result from this new drug, and also to see the possibility of using and applying this drug in a clinical trial in the future. Conclusion
  • 11.  H. P. Rang, M.M. Dale, J.M. Ritter, R.J. Flower, G. Henderson: Rang and Dale’s Pharmacology. 7th Edition. (Elsevier Inc. 2012). Chapters: 49-50  C.K.Bnniker, R.Ananthanarayan. Textbook of microbiology, 8th edition (Universities Press (India 2009-2010)). Chapters: 4, 5,6,66.  Richard A. Harvey, Pamela C. Champe: Lippincott’s Illustrated Reviews Microbiology. 2nd Edition. ( Lippincott’s Williams & Wiklins 2007). Chapter:19  Lectures, papers, journals about Animal Experiment provided by Maastricht University and Alrajhi Colleges. References